Last update 08 May 2025

Sellekstaurin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
Action
inhibitors
Mechanism
PKCβ inhibitors(Protein kinase C beta inhibitors)
Originator Organization
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
RegulationSpecial Review Project (China)
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
B-cell lymphoma recurrentNDA/BLA
China
06 Feb 2023
B-cell lymphoma refractoryNDA/BLA
China
06 Feb 2023
Diffuse Large B-Cell LymphomaNDA/BLA
China
06 Feb 2023
Follicular LymphomaNDA/BLA
China
06 Feb 2023
Mantle cell lymphoma refractoryNDA/BLA
China
06 Feb 2023
Marginal Zone B-Cell LymphomaNDA/BLA
China
06 Feb 2023
Chronic Lymphocytic LeukemiaNDA/BLA
United States
25 May 2018
LymphomaNDA/BLA
United States
25 May 2018
Small Lymphocytic LymphomaNDA/BLA
United States
25 May 2018
Lymphoid LeukemiaNDA/BLA--
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
45
(Cohort A)
(qvjpkqeetk) = The most common (>10%) were nausea (36%); diarrhea (29%); fatigue (18%); vomiting, anemia, and abdominal pain (13% each); and anorexia (11%) grdoeqwhmb (ycaobbjsnx )
Positive
15 Nov 2022
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free